U6 is not a suitable endogenous control for the quantification of circulating microRNAs

Biochemical and Biophysical Research Communications

Volumn 454, Issue 1, 2014, Pages 210-214

  Xiang, Mengqin ^a   Zeng, Ying ^a   Yang, Ruirui ^a   Xu, Haifan ^a   Chen, Zhuo ^a   Zhong, Jing ^a   Xie, Hailong ^a   Xu, Yinghui ^a   Zeng, Xi ^a  

^a UNIVERSITY OF SOUTH CHINA   (China)

Author keywords

Circulating microRNAs; Endogenous control; MiR 16; U6

Indexed keywords

MICRORNA; MICRORNA 16; MICRORNA 192; MICRORNA 24; MICRORNA U6; MIRNA 142 3P; MIRNA 19B; UNCLASSIFIED DRUG; MIRN16 MICRORNA, HUMAN; MIRN24 MICRORNA, HUMAN; RNA; SMALL NUCLEAR RNA; TUMOR MARKER; U6 SMALL NUCLEAR RNA;

ADULT; ARTICLE; BREAST CANCER; CANCER DIAGNOSIS; CANCER PATIENT; CANCER STAGING; COLORECTAL CANCER; CONTROLLED STUDY; FEMALE; GENE EXPRESSION PROFILING; HUMAN; MAJOR CLINICAL STUDY; MALE; MICROARRAY ANALYSIS; NASOPHARYNX CANCER; NASOPHARYNX CARCINOMA; POLYMERASE CHAIN REACTION; PROTEIN EXPRESSION; REFERENCE VALUE; STOMACH CANCER; AGED; BLOOD; BREAST TUMOR; CASE CONTROL STUDY; COLORECTAL TUMOR; DNA MICROARRAY; GENETICS; MIDDLE AGED; NASOPHARYNX TUMOR; STANDARD; STOMACH TUMOR; VALIDATION STUDY;

ADULT; AGED; BREAST NEOPLASMS; CASE-CONTROL STUDIES; COLORECTAL NEOPLASMS; FEMALE; HUMANS; MALE; MICRORNAS; MIDDLE AGED; NASOPHARYNGEAL NEOPLASMS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; REFERENCE STANDARDS; RNA, NEOPLASM; RNA, SMALL NUCLEAR; STOMACH NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 84910678143     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2014.10.064     Document Type: Article

References (43)

1. W.P. Kloosterman, R.H. Plasterk, The diverse functions of microRNAs in animal development and disease, Dev. Cell 11 (2006) 441-450.
2. G. Stefani, F.J. Slack, Small non-coding RNAs in animal development, Nat. Rev. Mol. Cell Biol. 9 (2008) 219-230.
3. Y.S. Lee, A. Dutta, MicroRNAs in cancer, Annu. Rev. Pathol. 4 (2009) 199-227.
4. P.S. Mitchell, R.K. Parkin, E.M. Kroh, B.R. Fritz, S.K. Wyman, E.L. Pogosova-Agadjanyan, A. Peterson, J. Noteboom, K.C. O'Briant, A. Allen, D.W. Lin, N. Urban, C.W. Drescher, B.S. Knudsen, D.L. Stirewalt, R. Gentleman, R.L. Vessella, P.S. Nelson, D.B. Martin, M. Tewari, Circulating microRNAs as stable blood-based markers for cancer detection, Proc. Natl. Acad. Sci. U.S.A. 105 (2008) 10513-10518.
5. X. Chen, Y. Ba, L. Ma, X. Cai, Y. Yin, K. Wang, J. Guo, Y. Zhang, J. Chen, X. Guo, Q. Li, X. Li, W. Wang, Y. Zhang, J. Wang, X. Jiang, Y. Xiang, C. Xu, P. Zheng, J. Zhang, R. Li, H. Zhang, X. Shang, T. Gong, G. Ning, J. Wang, K. Zen, J. Zhang, C.Y. Zhang, Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases, Cell Res. 18 (2008) 997-1006.
6. I. Sanders, S. Holdenrieder, G. Walgenbach-Brunagel, R.A. Von, G. Kristiansen, S.C. Muller, J. Ellinger, Evaluation of reference genes for the analysis of serum miRNA in patients with prostate cancer, bladder cancer and renal cell carcinoma, Int. J. Urol. 19 (2012) 1017-1025.
7. Z.H. Chen, G.L. Zhang, H.R. Li, J.D. Luo, Z.X. Li, G.M. Chen, J. Yang, A panel of five circulating microRNAs as potential biomarkers for prostate cancer, Prostate 72 (2012) 1443-1452.
8. L. Adam, M.F. Wszolek, C.G. Liu, W. Jing, L. Diao, A. Zien, J.D. Zhang, D. Jackson, C.P. Dinney, Plasma microRNA profiles for bladder cancer detection, Urol. Oncol. 31 (2013) 1701-1708.
9. M. Tsujiura, D. Ichikawa, S. Komatsu, A. Shiozaki, H. Takeshita, T. Kosuga, H. Konishi, R. Morimura, K. Deguchi, H. Fujiwara, K. Okamoto, E. Otsuji, Circulating microRNAs in plasma of patients with gastric cancers, Br. J. Cancer 102 (2010) 1174-1179.
10. K.E. Resnick, H. Alder, J.P. Hagan, D.L. Richardson, C.M. Croce, D.E. Cohn, The detection of differentially expressed microRNAs from the serum of ovarian cancer patients using a novel real-time PCR platform, Gynecol. Oncol. 112 (2009) 55-59.
11. R.J. Bryant, T. Pawlowski, J.W. Catto, G. Marsden, R.L. Vessella, B. Rhees, C. Kuslich, T. Visakorpi, F.C. Hamdy, Changes in circulating microRNA levels associated with prostate cancer, Br. J. Cancer 106 (2012) 768-774.
12. S. Miah, E. Dudziec, R.M. Drayton, A.R. Zlotta, S.L. Morgan, D.J. Rosario, F.C. Hamdy, J.W. Catto, An evaluation of urinary microRNA reveals a high sensitivity for bladder cancer, Br. J. Cancer 107 (2012) 123-128.
13. G. Wang, E.S. Chan, B.C. Kwan, P.K. Li, S.K. Yip, C.C. Szeto, C.F. Ng, Expression of microRNAs in the urine of patients with bladder cancer, Clin. Genitourin. Cancer 10 (2012) 106-113.
14. C.H. Lawrie, S. Gal, H.M. Dunlop, B. Pushkaran, A.P. Liggins, K. Pulford, A.H. Banham, F. Pezzella, J. Boultwood, J.S. Wainscoat, C.S. Hatton, A.L. Harris, Detection of elevated levels of tumour-associated microRNAs in serum of patients with diffuse large B-cell lymphoma, Br. J. Haematol. 141 (2008) 672-675.
15. H.M. Heneghan, N. Miller, A.J. Lowery, K.J. Sweeney, J. Newell, M.J. Kerin, Circulating microRNAs as novel minimally invasive biomarkers for breast cancer, Ann. Surg. 251 (2010) 499-505.
16. Z. Huang, D. Huang, S. Ni, Z. Peng, W. Sheng, X. Du, Plasma microRNAs are promising novel biomarkers for early detection of colorectal cancer, Int. J. Cancer 127 (2010) 118-126.
17. J. Wang, J. Chen, P. Chang, A. LeBlanc, D. Li, J.L. Abbruzzesse, M.L. Frazier, A.M. Killary, S. Sen, MicroRNAs in plasma of pancreatic ductal adenocarcinoma patients as novel blood-based biomarkers of disease, Cancer Prev. Res. (Phila) 2 (2009) 807-813.
18. T.S. Wong, X.B. Liu, B.Y. Wong, R.W. Ng, A.P. Yuen, W.I. Wei, Mature miR-184 as potential oncogenic microRNA of squamous cell carcinoma of tongue, Clin. Cancer Res. 14 (2008) 2588-2592.
19. M. Redova, A. Poprach, J. Nekvindova, R. Iliev, L. Radova, R. Lakomy, M. Svoboda, R. Vyzula, O. Slaby, Circulating miR-378 and miR-451 in serum are potential biomarkers for renal cell carcinoma, J. Transl. Med. 10 (2012) 55.
20. A. Watahiki, R.J. Macfarlane, M.E. Gleave, F. Crea, Y. Wang, C.D. Helgason, K.N. Chi, Plasma miRNAs as biomarkers to identify patients with castration-resistant metastatic prostate cancer, Int. J. Mol. Sci. 14 (2013) 7757-7770.
21. C. Vasilescu, S. Rossi, M. Shimizu, S. Tudor, A. Veronese, M. Ferracin, M.S. Nicoloso, E. Barbarotto, M. Popa, O. Stanciulea, M.H. Fernandez, D. Tulbure, C.E. Bueso-Ramos, M. Negrini, G.A. Calin, MicroRNA fingerprints identify miR-150 as a plasma prognostic marker in patients with sepsis, PLoS ONE 4 (2009) e7405.
22. M. Tanaka, K. Oikawa, M. Takanashi, M. Kudo, J. Ohyashiki, K. Ohyashiki, M. Kuroda, Down-regulation of miR-92 in human plasma is a novel marker for acute leukemia patients, PLoS ONE 4 (2009) e5532.
23. B.M. Von, J.J. Pandarakalam, L. Kroon, H. Loeser, J. Herden, G. Braun, K. Wendland, H.P. Dienes, U. Engelmann, J.W. Fries, MicroRNA 15a, inversely correlated to PKCalpha, is a potential marker to differentiate between benign and malignant renal tumors in biopsy and urine samples, Am. J. Pathol. 180 (2012) 1787-1797.
24. A. Zhao, G. Li, M. Peoc'h, C. Genin, M. Gigante, Serum miR-210 as a novel biomarker for molecular diagnosis of clear cell renal cell carcinoma, Exp. Mol. Pathol. 94 (2013) 115-120.
25. W. Zhu, W. Qin, U. Atasoy, E.R. Sauter, Circulating microRNAs in breast cancer and healthy subjects, BMC Res. Notes 2 (2009) 89.
26. G. Reid, M.B. Kirschner, N. van Zandwijk, Circulating microRNAs: association with disease and potential use as biomarkers, Crit. Rev. Oncol. Hematol. 80 (2011) 193-208.
27. A.S. Ho, X. Huang, H. Cao, C. Christman-Skieller, K. Bennewith, Q.T. Le, A.C. Koong, Circulating miR-210 as a novel hypoxia marker in pancreatic cancer, Transl. Oncol. 3 (2010) 109-113.
28. J.F. Wang, M.L. Yu, G. Yu, J.J. Bian, X.M. Deng, X.J. Wan, K.M. Zhu, Serum miR-146a and miR-223 as potential new biomarkers for sepsis, Biochem. Biophys. Res. Commun. 394 (2010) 184-188.
29. J.C. Brase, M. Johannes, T. Schlomm, M. Falth, A. Haese, T. Steuber, T. Beissbarth, R. Kuner, H. Sultmann, Circulating miRNAs are correlated with tumor progression in prostate cancer, Int. J. Cancer 128 (2011) 608-616.
30. L.A. Selth, S. Townley, J.L. Gillis, A.M. Ochnik, K. Murti, R.J. Macfarlane, K.N. Chi, V.R. Marshall, W.D. Tilley, L.M. Butler, Discovery of circulating microRNAs associated with human prostate cancer using a mouse model of disease, Int. J. Cancer 131 (2012) 652-661.
31. H.C. Nguyen, W. Xie, M. Yang, C.L. Hsieh, S. Drouin, G.S. Lee, P.W. Kantoff, Expression differences of circulating microRNAs in metastatic castration resistant prostate cancer and low-risk, localized prostate cancer, Prostate 73 (2013) 346-354.
32. S. Hauser, L.M. Wulfken, S. Holdenrieder, R. Moritz, C.H. Ohlmann, V. Jung, F. Becker, E. Herrmann, G. Walgenbach-Brunagel, R.A. Von, S.C. Muller, J. Ellinger, Analysis of serum microRNAs (miR-26a-2?, miR-191, miR-337-3p and miR-378) as potential biomarkers in renal cell carcinoma, Cancer Epidemiol. 36 (2012) 391-394.
33. Z. Hu, X. Chen, Y. Zhao, T. Tian, G. Jin, Y. Shu, Y. Chen, L. Xu, K. Zen, C. Zhang, H. Shen, Serum microRNA signatures identified in a genome-wide serum microRNA expression profiling predict survival of non-small-cell lung cancer, J. Clin. Oncol. 28 (2010) 1721-1726.
34. R. Liu, C. Zhang, Z. Hu, G. Li, C. Wang, C. Yang, D. Huang, X. Chen, H. Zhang, R. Zhuang, T. Deng, H. Liu, J. Yin, S. Wang, K. Zen, Y. Ba, C.Y. Zhang, A five-microRNA signature identified from genome-wide serum microRNA expression profiling serves as a fingerprint for gastric cancer diagnosis, Eur. J. Cancer 47 (2011) 784-791.
35. S.S. Chim, T.K. Shing, E.C. Hung, T.Y. Leung, T.K. Lau, R.W. Chiu, Y.M. Lo, Detection and characterization of placental microRNAs in maternal plasma, Clin. Chem. 54 (2008) 482-490.
36. H.M. Heneghan, N. Miller, M.J. Kerin, Circulating miRNA signatures: promising prognostic tools for cancer, J. Clin. Oncol. 28 (2010) e573-574 (author reply e575-576).
37. X. Zeng, J. Xiang, M. Wu, W. Xiong, H. Tang, M. Deng, X. Li, Q. Liao, B. Su, Z. Luo, Y. Zhou, M. Zhou, Z. Zeng, X. Li, S. Shen, C. Shuai, G. Li, J. Fang, S. Peng, Circulating miR-17, miR-20a, miR-29c, and miR-223 combined as non-invasive biomarkers in nasopharyngeal carcinoma, PLoS ONE 7 (2012) e46367.
38. D. Wylie, J. Shelton, A. Choudhary, A.T. Adai, A novel mean-centering method for normalizing microRNA expression from high-throughput RT-qPCR data, BMC Res. Notes 4 (2011) 555.
39. V. Koberle, T. Pleli, C. Schmithals, A.E. Augusto, J. Haupenthal, H. Bonig, J. Peveling-Oberhag, R.M. Biondi, S. Zeuzem, B. Kronenberger, O. Waidmann, A. Piiper, Differential stability of cell-free circulating microRNAs: implications for their utilization as biomarkers, PLoS ONE 8 (2013) e75184.
40. M.L. Squadrito, C. Baer, F. Burdet, C. Maderna, G.D. Gilfillan, R. Lyle, M. Ibberson, M. De Palma, Endogenous RNAs modulate MicroRNA sorting to exosomes and transfer to acceptor cells, Cell Rep. 8 (2014) 1432-1446.
41. D.M. Pegtel, L. Peferoen, S. Amor, Extracellular vesicles as modulators of cell-to-cell communication in the healthy and diseased brain, Philos. Trans. R. Soc. Lond. B Biol. Sci. 369 (2014).
42. A. Suetsugu, K. Honma, S. Saji, H. Moriwaki, T. Ochiya, R.M. Hoffman, Imaging exosome transfer from breast cancer cells to stroma at metastatic sites in orthotopic nude-mouse models, Adv. Drug Deliv. Rev. 65 (2013) 383-390.
43. N.P. Hessvik, K. Sandvig, A. Llorente, Exosomal miRNAs as biomarkers for prostate cancer, Front. Genet. 4 (2013) 36.